We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$666B
AUM Growth
+$8.72B
Cap. Flow
+$1.57B
Cap. Flow %
0.24%
Top 10 Hldgs %
22.76%
Holding
14,701
New
2,078
Increased
5,000
Reduced
5,362
Closed
2,191

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$775M
2
ABBV icon
AbbVie
ABBV
+$540M
3
DAL icon
Delta Air Lines
DAL
+$434M
4
LLY icon
Eli Lilly
LLY
+$433M
5
DXCM icon
DexCom
DXCM
+$433M

Sector Composition

Rank Sector Weight
1 Technology 4.89%
2 Healthcare 2.92%
3 Financials 2.71%
4 Consumer Discretionary 2.52%
5 Industrials 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HGTY icon
10101
PUT
Hagerty
HGTY
$1.37B
$301K ﹤0.01%
22,400
-900
-4% -$11.2K
IDNA icon
10102
iShares Genomics Immunology and Healthcare ETF
IDNA
$198M
$301K ﹤0.01%
11,490
-12,759
-53% -$328K
DV icon
10103
PUT
DoubleVerify
DV
$1.8B
$301K ﹤0.01%
26,300
-18,500
-41% -$204K
MOAT icon
10104
CALL
VanEck Morningstar Wide Moat ETF
MOAT
$12.1B
$300K ﹤0.01%
2,900
-1,000
-26% -$102K
IDUB icon
10105
Aptus International Enhanced Yield ETF
IDUB
$510M
$300K ﹤0.01%
+12,338
New +$296K
PBBK
10106
DELISTED
PB Bankshares
PBBK
$300K ﹤0.01%
+14,187
New +$292K
TSLT icon
10107
T-REX 2X Long Tesla Daily Target ETF
TSLT
$148M
$300K ﹤0.01%
11,233
-3,723
-25% -$101K
TEMT
10108
CALL
Tradr 2X Long TEM Daily ETF
TEMT
$28.9M
$300K ﹤0.01%
8,733
+5,233
+150% +$432K
RZLT icon
10109
CALL
Rezolute
RZLT
$453M
$300K ﹤0.01%
127,100
+87,300
+219% +$684K
NWLG
10110
DELISTED
Nuveen Winslow Large-Cap Growth ESG ETF
NWLG
$300K ﹤0.01%
+7,887
New +$301K
FNGR icon
10111
CALL
FingerMotion
FNGR
$21.5M
$300K ﹤0.01%
243,700
+4,500
+2% +$6.68K
FULC icon
10112
CALL
Fulcrum Therapeutics
FULC
$288M
$300K ﹤0.01%
26,500
-7,900
-23% -$80.4K
LAUR icon
10113
PUT
Laureate Education
LAUR
$5.14B
$300K ﹤0.01%
+8,900
New +$275K
BTSG icon
10114
PUT
BrightSpring Health Services
BTSG
$12B
$300K ﹤0.01%
8,000
-23,600
-75% -$791K
SYZ
10115
Lazard US Systematic Small Cap Equity ETF
SYZ
$68M
$299K ﹤0.01%
+11,844
New +$294K
ARCO icon
10116
CALL
Arcos Dorados Holdings
ARCO
$1.76B
$299K ﹤0.01%
40,800
-12,500
-23% -$90K
KULR icon
10117
PUT
KULR Technology Group
KULR
$128M
$299K ﹤0.01%
101,155
+29,645
+41% +$109K
EMBC icon
10118
CALL
Embecta
EMBC
$208M
$299K ﹤0.01%
25,200
+1,500
+6% +$19.8K
FFTY icon
10119
CALL
CapForce IBD 50 ETF
FFTY
$79.5M
$299K ﹤0.01%
8,600
+1,600
+23% +$59K
ANRO icon
10120
CALL
Alto Neuroscience
ANRO
$1.11B
$299K ﹤0.01%
+16,800
New +$212K
MCGA
10121
PUT
Yorkville Acquisition Corp
MCGA
$241M
$299K ﹤0.01%
+29,500
New +$304K
SPWH icon
10122
Sportsman's Warehouse
SPWH
$46M
$299K ﹤0.01%
204,502
-128,299
-39% -$279K
CDLX icon
10123
CALL
Cardlytics
CDLX
$20.4M
$299K ﹤0.01%
25,960
-10,740
-29% -$166K
STOK icon
10124
PUT
Stoke Therapeutics
STOK
$2.06B
$298K ﹤0.01%
+9,400
New +$283K
STXF
10125
Strive 500 ETF
STXF
$1.16B
$298K ﹤0.01%
+6,762
New +$296K

Similar funds

Citadel Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.

By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
  • Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
  • Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
  • Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
  • Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
  • Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
  • Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.